Login / Signup

Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients.

Christopher S StrouseSarah L MottBrian J SmithMargarida Magalhaes-SilvermanUmar FarooqFenghuang ZhanYogesh JethavaGuido Tricot
Published in: Bone marrow transplantation (2023)
Keyphrases
  • multiple myeloma
  • high dose
  • low dose